Nicos Kessaris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nicos Kessaris has a total of 184 co-authors. Here are the top co-authors by number of shared publications:
Ioannis Loukopoulos
Department of Nephrology and Transplantation Guy's Hospital London UK
4 shared publications- Nizam Mamode
Guy’s and St Thomas’ NHS Foundation Trust
4 shared publications - Colin Forman
Department of Vascular Surgery, Royal Free Hospital, London, UK
3 shared publications Francis Calder
Department of Nephrology and Transplantation Guy's Hospital London UK
3 shared publications- Ioannis D. Kostakis
Department of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK
3 shared publications - Jelena Stojanovic
Great Ormond Street Hospital for Children NHS Foundation Trust, United Kingdom
3 shared publications
Latest Publications
- 20 May 2023
- Published by Springer Nature in Pediatric Nephrology
- Vol. 38 (11) , 3803-3810
Long term outcomes following kidney transplantation in children who weighed less than 15 kg – report from the UK Transplant Registry
Background Kidney transplantation is the treatment of choice in chronic kidney disease (CKD) stage 5. It is often delayed in younger children until a target weight is achieved due to technical feasibility and historic concerns about poorer outcomes. Methods Data on all first paediatric (aged < 18 years) kidney only transplants performed in the United Kingdom between 1 January 2006 and 31 December 2016 were extracted from the UK Transplant Registry (n = 1,340). Children were categorised by weight at the time of transplant into those < 15 kg and those ≥ 15 kg. Donor, recipient and transplant characteristics were compared between groups using chi-squared or Fisher’s exact test for categorical variables and Kruskal–Wallis test for continuous variables. Thirty day, one-year, five-year and ten-year patient and kidney allograft survival were compared using the Kaplan–Meier method. Results There was no difference in patient survival following kidney transplantation when comparing children < 15 kg with those ≥ 15 kg. Ten-year kidney allograft survival was significantly better for children < 15 kg than children ≥ 15 kg (85.4% vs. 73.5% respectively, p = 0.002). For children < 15 kg, a greater proportion of kidney transplants were from living donors compared with children ≥ 15 kg (68.3% vs. 49.6% respectively, p < 0.001). There was no difference in immediate graft function between the groups (p = 0.54) and delayed graft function was seen in 4.8% and 6.8% of children < 15 kg and ≥ 15 kg respectively. Conclusions Our study reports significantly better ten-year kidney allograft survival in children < 15 kg and supports consideration of earlier transplantation for children with CKD stage 5. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 20 May 2023
- Published by Springer Nature in Pediatric Nephrology
- Vol. 38 (11) , 3803-3810
Long term outcomes following kidney transplantation in children who weighed less than 15 kg – report from the UK Transplant Registry
Background Kidney transplantation is the treatment of choice in chronic kidney disease (CKD) stage 5. It is often delayed in younger children until a target weight is achieved due to technical feasibility and historic concerns about poorer outcomes. Methods Data on all first paediatric (aged < 18 years) kidney only transplants performed in the United Kingdom between 1 January 2006 and 31 December 2016 were extracted from the UK Transplant Registry (n = 1,340). Children were categorised by weight at the time of transplant into those < 15 kg and those ≥ 15 kg. Donor, recipient and transplant characteristics were compared between groups using chi-squared or Fisher’s exact test for categorical variables and Kruskal–Wallis test for continuous variables. Thirty day, one-year, five-year and ten-year patient and kidney allograft survival were compared using the Kaplan–Meier method. Results There was no difference in patient survival following kidney transplantation when comparing children < 15 kg with those ≥ 15 kg. Ten-year kidney allograft survival was significantly better for children < 15 kg than children ≥ 15 kg (85.4% vs. 73.5% respectively, p = 0.002). For children < 15 kg, a greater proportion of kidney transplants were from living donors compared with children ≥ 15 kg (68.3% vs. 49.6% respectively, p < 0.001). There was no difference in immediate graft function between the groups (p = 0.54) and delayed graft function was seen in 4.8% and 6.8% of children < 15 kg and ≥ 15 kg respectively. Conclusions Our study reports significantly better ten-year kidney allograft survival in children < 15 kg and supports consideration of earlier transplantation for children with CKD stage 5. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- Open Access
- 18 January 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (3) , e14470
Pediatric renal transplantation—A UNOS database analysis of donor–recipient size mismatch
Background: We used the BSAi (Donor BSA/Recipient BSA) to assess whether transplanting a small or large kidney into a pediatric recipient relative to his/her size influences renal transplant outcomes.Methods: We included 14 322 single‐kidney transplants in pediatric recipients (0–17 years old) (01/2000–02/2020) from the United Network for Organ Sharing database. We divided cases into four BSAi groups (BSAi ≤ 1, 1 < BSAi ≤ 2, 2 < BSAi ≤ 3, BSAi > 3).Results: There were no differences concerning delayed graft function (DGF) or primary non‐function (PNF) rates, whether the grafts were from living or brain‐dead donors. In both transplants coming from living donors and brain‐dead donors, cases with BSAi > 3 and cases with 2 < BSAi ≤ 3 had similar graft survival (p = .13 for transplants from living donors, p = .413 for transplants from brain‐dead donors), and both groups had longer graft survival than cases with 1 < BSAi ≤ 2 and cases with BSAi ≤ 1 (p < .001). The difference in 10‐year graft survival rates between cases with BSAi > 3 and cases with BSAi ≤ 1 reached around 25% in both donor types. The better graft survival in transplants with BSAi > 2 was confirmed in multivariable analysis.Conclusions: There is no significant impact of donor‐recipient size mismatch on DGF and PNF rates in pediatric renal transplants. However, graft survival is significantly improved when the donor's size is more than twice the pediatric recipient's size.
- 18 January 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (3) , e14470
Open AccessPediatric renal transplantation—A UNOS database analysis of donor–recipient size mismatch
Background: We used the BSAi (Donor BSA/Recipient BSA) to assess whether transplanting a small or large kidney into a pediatric recipient relative to his/her size influences renal transplant outcomes.Methods: We included 14 322 single‐kidney transplants in pediatric recipients (0–17 years old) (01/2000–02/2020) from the United Network for Organ Sharing database. We divided cases into four BSAi groups (BSAi ≤ 1, 1 < BSAi ≤ 2, 2 < BSAi ≤ 3, BSAi > 3).Results: There were no differences concerning delayed graft function (DGF) or primary non‐function (PNF) rates, whether the grafts were from living or brain‐dead donors. In both transplants coming from living donors and brain‐dead donors, cases with BSAi > 3 and cases with 2 < BSAi ≤ 3 had similar graft survival (p = .13 for transplants from living donors, p = .413 for transplants from brain‐dead donors), and both groups had longer graft survival than cases with 1 < BSAi ≤ 2 and cases with BSAi ≤ 1 (p < .001). The difference in 10‐year graft survival rates between cases with BSAi > 3 and cases with BSAi ≤ 1 reached around 25% in both donor types. The better graft survival in transplants with BSAi > 2 was confirmed in multivariable analysis.Conclusions: There is no significant impact of donor‐recipient size mismatch on DGF and PNF rates in pediatric renal transplants. However, graft survival is significantly improved when the donor's size is more than twice the pediatric recipient's size.
- 12 November 2022
- Published by Springer Nature
- p. 149-185
Live Donor Nephrectomy: Current Techniques and Safety Profiles
- 12 November 2022
- Published by Springer Nature
- p. 149-185
Live Donor Nephrectomy: Current Techniques and Safety Profiles
- 1 August 2022
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 104, 106711
How crises work: A model of error cause and effect in surgical practice
Introduction: Surgical crises have major consequences for patients, staff and healthcare institutions. Nevertheless, their aetiology and evolution are poorly understood outside the remit of root-cause analyses. Aims: To develop a crisis model in surgery in order to aid the reporting and management of safety critical events. Methods: A narrative review surveyed the safety literature on failure causes, mechanisms and effects in the context of surgical crises. Sources were identified using non-probability sampling, with selection and inclusion being determined by author panel consensus. The data underwent thematic analysis and reporting followed the recommendation of the SALSA framework. Results: Data from 133 sources derived five principal themes. Analysis suggested that surgical care processes become destabilized in a step-wise manner. This crisis chain is initiated by four categories of threat or risk: (i) the systems in which surgeons operate; (ii) surgeons' technical, cognitive and behavioural skills; (iii) surgeons' physiological and psychological state (operational condition); and (iv) professional culture. Once triggered, the crisis chain is driven by only three types of errors: Type I. Performance errors consist of failures to diagnose, plan or execute tasks; Type II. Awareness errors are failures to recognise, comprehend or extrapolate the impact of performance failures; Type III. Rescue errors represent failures to correct faulty performance. The co-occurrence of all three error types gives rise to harm, which can lead to a crisis in the absence of mitigating actions. Conclusion: Surgical crises may be triggered by four categories of threat and driven by only three types of error. These may represent universal targets for safety interventions that create new opportunities for crisis management.
- 1 August 2022
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 104, 106711
How crises work: A model of error cause and effect in surgical practice
Introduction: Surgical crises have major consequences for patients, staff and healthcare institutions. Nevertheless, their aetiology and evolution are poorly understood outside the remit of root-cause analyses. Aims: To develop a crisis model in surgery in order to aid the reporting and management of safety critical events. Methods: A narrative review surveyed the safety literature on failure causes, mechanisms and effects in the context of surgical crises. Sources were identified using non-probability sampling, with selection and inclusion being determined by author panel consensus. The data underwent thematic analysis and reporting followed the recommendation of the SALSA framework. Results: Data from 133 sources derived five principal themes. Analysis suggested that surgical care processes become destabilized in a step-wise manner. This crisis chain is initiated by four categories of threat or risk: (i) the systems in which surgeons operate; (ii) surgeons' technical, cognitive and behavioural skills; (iii) surgeons' physiological and psychological state (operational condition); and (iv) professional culture. Once triggered, the crisis chain is driven by only three types of errors: Type I. Performance errors consist of failures to diagnose, plan or execute tasks; Type II. Awareness errors are failures to recognise, comprehend or extrapolate the impact of performance failures; Type III. Rescue errors represent failures to correct faulty performance. The co-occurrence of all three error types gives rise to harm, which can lead to a crisis in the absence of mitigating actions. Conclusion: Surgical crises may be triggered by four categories of threat and driven by only three types of error. These may represent universal targets for safety interventions that create new opportunities for crisis management.
- Open Access
- 6 July 2022
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (9) , 3367-3375
Presentation, treatment, and outcome of renovascular hypertension below 2 years of age
Renovascular hypertension in most cases requires endovascular treatment and/or surgery. This is technically much more difficult in small children and there is very limited published knowledge in this age group. We here present treatment and outcome of young children with renovascular hypertension at our institution. Children below 2 years of age, with renovascular hypertension between January 1998 and March 2020 were retrospectively reviewed. Demographics and treatment modalities were noted. Primary outcome was blood pressure within a week after the procedures and at last available visit. Sixty-six angiographies were performed in 34 patients. Median age at time of first angiography was 1.03 (interquartile range (IQR) 0.4–1.4) years and systolic blood pressure at presentation 130 (IQR 130–150) mm Hg. Thirty-eight percent (13/34) of children were incidentally diagnosed and 18% (6/34) presented with heart failure. Twenty-six (76%) children had main renal artery stenosis and 17 (50%) mid-aortic syndrome. Seventeen (50%) children showed intrarenal, six (18%) mesenteric, and three (9%) cerebrovascular involvement. Twenty patients underwent 45 percutaneous transluminal angioplasty procedures and seven children surgeries. In 44% of the 16 patients who underwent only percutaneous transluminal angioplasty blood pressure was normalized, 38% had improvement on same or decreased treatment and 19% showed no improvement. Complications were seen in 7.5% (5/66) of angiographies. In four of the seven (57%) children who underwent surgery blood pressure was normalized, two had improved (29%) and one unchanged (14%) blood pressure.Conclusion: In small children with renovascular hypertension below the age of 2 years, percutaneous transluminal angioplasty caused significant improvement in blood pressure with low complication profile. Surgery can be recommended where percutaneous transluminal angioplasty and medical treatments failed. What is Known:• Renovascular hypertension is diagnosed in all age groups from a few weeks of life until adulthood.• Both angioplasty and surgery are significantly more difficult to perform in small children and the published information on short and long-term outcome in these children is very scarce. What is New:• Children below the age of two years can safely and successfully undergo selective renal angiography and also safely be treated with angioplasty.• We here present a large group of babies and infants where angioplasty and in some cases surgery effectively and safely improved their blood pressure.
- 6 July 2022
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (9) , 3367-3375
Open AccessPresentation, treatment, and outcome of renovascular hypertension below 2 years of age
Renovascular hypertension in most cases requires endovascular treatment and/or surgery. This is technically much more difficult in small children and there is very limited published knowledge in this age group. We here present treatment and outcome of young children with renovascular hypertension at our institution. Children below 2 years of age, with renovascular hypertension between January 1998 and March 2020 were retrospectively reviewed. Demographics and treatment modalities were noted. Primary outcome was blood pressure within a week after the procedures and at last available visit. Sixty-six angiographies were performed in 34 patients. Median age at time of first angiography was 1.03 (interquartile range (IQR) 0.4–1.4) years and systolic blood pressure at presentation 130 (IQR 130–150) mm Hg. Thirty-eight percent (13/34) of children were incidentally diagnosed and 18% (6/34) presented with heart failure. Twenty-six (76%) children had main renal artery stenosis and 17 (50%) mid-aortic syndrome. Seventeen (50%) children showed intrarenal, six (18%) mesenteric, and three (9%) cerebrovascular involvement. Twenty patients underwent 45 percutaneous transluminal angioplasty procedures and seven children surgeries. In 44% of the 16 patients who underwent only percutaneous transluminal angioplasty blood pressure was normalized, 38% had improvement on same or decreased treatment and 19% showed no improvement. Complications were seen in 7.5% (5/66) of angiographies. In four of the seven (57%) children who underwent surgery blood pressure was normalized, two had improved (29%) and one unchanged (14%) blood pressure.Conclusion: In small children with renovascular hypertension below the age of 2 years, percutaneous transluminal angioplasty caused significant improvement in blood pressure with low complication profile. Surgery can be recommended where percutaneous transluminal angioplasty and medical treatments failed. What is Known:• Renovascular hypertension is diagnosed in all age groups from a few weeks of life until adulthood.• Both angioplasty and surgery are significantly more difficult to perform in small children and the published information on short and long-term outcome in these children is very scarce. What is New:• Children below the age of two years can safely and successfully undergo selective renal angiography and also safely be treated with angioplasty.• We here present a large group of babies and infants where angioplasty and in some cases surgery effectively and safely improved their blood pressure.
- Open Access
- 16 March 2022
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 8 (4) , e1284
Simultaneous Kidney and Parathyroid Transplantation in the Management of Genetic Hypoparathyroidism in a Child
Background. Genetically determined hypoparathyroidism can lead to life-threatening episodes of hypocalcemia and, more rarely, to end-stage kidney disease at a young age. Parathyroid allotransplantation is the only curative treatment, and in patients already receiving immunosuppression for kidney transplantation, there may be little additional risk involved. We report the first such case in a child. Methods. An 11-y-old girl, known to have hypoparathyroidism secondary to an activating pathogenic variant in the calcium-sensing receptor, developed end-stage kidney disease and was started on intermittent hemodialysis. Since the age of 2.5 y, she had been receiving treatment with exogenous synthetic parathyroid hormone (PTH). In June 2019, at the age of 11.8 y, she received a living-donor kidney and simultaneous parathyroid gland transplant from her father. The kidney was implanted into the right iliac fossa, followed by implantation of the parathyroid gland into the exposed rectus muscle. Results. The kidney graft showed immediate function while the intrinsic serum PTH level remained low at 3 ng/L. Exogenous PTH infusion was reduced on day 6 posttransplantation to stimulate PTH production by the new gland, which resulted in improving intrinsic PTH concentrations of 28 ng/L by day 9. Twelve months after transplantation, PTH levels remain in normal range and the kidney graft function is stable with a serum creatinine of 110 μmol/L. Conclusions. Simultaneous living donation and transplantation of a kidney and a parathyroid gland into a child is safe and feasible and has the potential to cure primary hypoparathyroidism as well as kidney failure.
- 16 March 2022
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 8 (4) , e1284
Open AccessSimultaneous Kidney and Parathyroid Transplantation in the Management of Genetic Hypoparathyroidism in a Child
Background. Genetically determined hypoparathyroidism can lead to life-threatening episodes of hypocalcemia and, more rarely, to end-stage kidney disease at a young age. Parathyroid allotransplantation is the only curative treatment, and in patients already receiving immunosuppression for kidney transplantation, there may be little additional risk involved. We report the first such case in a child. Methods. An 11-y-old girl, known to have hypoparathyroidism secondary to an activating pathogenic variant in the calcium-sensing receptor, developed end-stage kidney disease and was started on intermittent hemodialysis. Since the age of 2.5 y, she had been receiving treatment with exogenous synthetic parathyroid hormone (PTH). In June 2019, at the age of 11.8 y, she received a living-donor kidney and simultaneous parathyroid gland transplant from her father. The kidney was implanted into the right iliac fossa, followed by implantation of the parathyroid gland into the exposed rectus muscle. Results. The kidney graft showed immediate function while the intrinsic serum PTH level remained low at 3 ng/L. Exogenous PTH infusion was reduced on day 6 posttransplantation to stimulate PTH production by the new gland, which resulted in improving intrinsic PTH concentrations of 28 ng/L by day 9. Twelve months after transplantation, PTH levels remain in normal range and the kidney graft function is stable with a serum creatinine of 110 μmol/L. Conclusions. Simultaneous living donation and transplantation of a kidney and a parathyroid gland into a child is safe and feasible and has the potential to cure primary hypoparathyroidism as well as kidney failure.
- Open Access
Multicentre randomised controlled trial: protocol for Plasma-Lyte Usage and Assessment of Kidney Transplant Outcomes in Children (PLUTO)
Introduction Acute electrolyte and acid–base imbalance is experienced by many children following kidney transplantation. When severe, this can lead to complications including seizures, cerebral oedema and death. Relatively large volumes of intravenous fluid are administered to children perioperatively in order to establish perfusion to the donor kidney, the majority of which are from living and deceased adult donors. Hypotonic intravenous fluid is commonly used in the post-transplant period due to clinicians’ concerns about the sodium, chloride and potassium content of isotonic alternatives when administered in large volumes. Plasma-Lyte 148 is an isotonic, balanced intravenous fluid that contains sodium, chloride, potassium and magnesium with concentrations equivalent to those of plasma. There is a physiological basis to expect that Plasma-Lyte 148 will reduce the incidence of clinically significant electrolyte and acid–base abnormalities in children following kidney transplantation compared with current practice. The aim of the PLUTO trial is to determine whether the incidence of clinically significantly abnormal plasma electrolyte levels in paediatric kidney transplant recipients will be different with the use of Plasma-Lyte-148 compared to intravenous fluid currently administered. Methods and analysis PLUTO is a pragmatic, open-label, randomised controlled trial comparing Plasma-Lyte 148 to current care in paediatric kidney transplant recipients, conducted in nine UK paediatric kidney transplant centres. A total of 144 children receiving kidney transplants will be randomised to receive either Plasma-Lyte 148 (the intervention) intraoperatively and postoperatively, or current fluid. Apart from intravenous fluid composition, all participants will receive standard clinical transplant care. The primary outcome measure is acute hyponatraemia in the first 72 hours post-transplant, defined as laboratory plasma sodium concentration of Ethics and dissemination The trial received Health Research Authority approval on 20 January 2020. Findings will be presented to academic groups via national and international conferences and peer-reviewed journals. The patient and public involvement group will play an important part in disseminating the study findings to the public domain. Trial registration numbers 2019-003025-22 and 16586164.
Open AccessMulticentre randomised controlled trial: protocol for Plasma-Lyte Usage and Assessment of Kidney Transplant Outcomes in Children (PLUTO)
Introduction Acute electrolyte and acid–base imbalance is experienced by many children following kidney transplantation. When severe, this can lead to complications including seizures, cerebral oedema and death. Relatively large volumes of intravenous fluid are administered to children perioperatively in order to establish perfusion to the donor kidney, the majority of which are from living and deceased adult donors. Hypotonic intravenous fluid is commonly used in the post-transplant period due to clinicians’ concerns about the sodium, chloride and potassium content of isotonic alternatives when administered in large volumes. Plasma-Lyte 148 is an isotonic, balanced intravenous fluid that contains sodium, chloride, potassium and magnesium with concentrations equivalent to those of plasma. There is a physiological basis to expect that Plasma-Lyte 148 will reduce the incidence of clinically significant electrolyte and acid–base abnormalities in children following kidney transplantation compared with current practice. The aim of the PLUTO trial is to determine whether the incidence of clinically significantly abnormal plasma electrolyte levels in paediatric kidney transplant recipients will be different with the use of Plasma-Lyte-148 compared to intravenous fluid currently administered. Methods and analysis PLUTO is a pragmatic, open-label, randomised controlled trial comparing Plasma-Lyte 148 to current care in paediatric kidney transplant recipients, conducted in nine UK paediatric kidney transplant centres. A total of 144 children receiving kidney transplants will be randomised to receive either Plasma-Lyte 148 (the intervention) intraoperatively and postoperatively, or current fluid. Apart from intravenous fluid composition, all participants will receive standard clinical transplant care. The primary outcome measure is acute hyponatraemia in the first 72 hours post-transplant, defined as laboratory plasma sodium concentration of Ethics and dissemination The trial received Health Research Authority approval on 20 January 2020. Findings will be presented to academic groups via national and international conferences and peer-reviewed journals. The patient and public involvement group will play an important part in disseminating the study findings to the public domain. Trial registration numbers 2019-003025-22 and 16586164.
- Open Access
- 1 November 2021
- Published by Elsevier in Journal of Pediatric Surgery Case Reports
- Vol. 74
Renal artery aneurysm repair by auto-transplantation in a 4-year-old girl with renovascular hypertension
- 1 November 2021
- Published by Elsevier in Journal of Pediatric Surgery Case Reports
- Vol. 74
Open AccessRenal artery aneurysm repair by auto-transplantation in a 4-year-old girl with renovascular hypertension
- Open Access
- 30 September 2021
- Published by BMJ
- Vol. 106 (Suppl 1) , A95-A96
726 A state of the art: using 3D models to allow better planning of complex vascular surgeries and enhancing safety in children
Background 3D organ printing allows better surgical planning and enhances safety for complex cardiac and renal transplant surgeries in adults. We present the use of 3D printing of abdominal organs and vessels for two paediatric patients with complex renovascular disease who underwent aortic graft bypass and bilateral renal auto-transplant. To our knowledge, this is the first use of 3D printing for this cohort of complex patients. Objectives To explore ways in which complex surgeries in children can be improved allowing for optimal multidisciplinary surgical planning, contributing to better consent process and enhancing patient safety. Methods We used 2D abdominal MRI to create a 3D model of kidneys, abdominal aorta, IVC and pancreas. Segmentation, the process of converting 2D slice data CTA scans to 3D surface models, was completed in Materialise Mimics. This surface model was exported as an STL file and then printed using a Stratasys Objet260 Connex3 polyjet printer. Soluble support was used for minimal post-print clean up. All of this in the laboratory at Great Ormond Street Hospital for Children. Results The first patient was a 7 year old girl with a background of neurofibromatosis type 1 who underwent left nephrectomy and had 7 angioplasties on the remaining right kidney. An aortic bypass was performed and the kidney was successfully auto-transplanted onto the right iliac vessels. The second patient was a 2 year old boy with middle aortic syndrome in which a bypass was performed from the thoracic aorta to the aortic iliac bifurcation with successful bilateral renal auto-transplantation. 3D models allowed the team for better planning of surgical approach and in the first case, initially planned surgical approach was amended once the model was reviewed. Patients and families commented that seeing the model made them better understand the operation and it contributed to better patient information and consenting pathway. Conclusions This is the first report on the use of the 3D printing for planning of complex vascular surgeries involving major arteries in children with renovascular hypertension and associated severe middle aortic syndrome. Both cases were successfully performed and 3D models benefitted both the surgical and medical planning, enhances safety of complex procedures,; as well as improving family understanding of the complexity of the procedure and adding to the quality of informed consent.
- 30 September 2021
- Published by BMJ
- Vol. 106 (Suppl 1) , A95-A96
Open Access726 A state of the art: using 3D models to allow better planning of complex vascular surgeries and enhancing safety in children
Background 3D organ printing allows better surgical planning and enhances safety for complex cardiac and renal transplant surgeries in adults. We present the use of 3D printing of abdominal organs and vessels for two paediatric patients with complex renovascular disease who underwent aortic graft bypass and bilateral renal auto-transplant. To our knowledge, this is the first use of 3D printing for this cohort of complex patients. Objectives To explore ways in which complex surgeries in children can be improved allowing for optimal multidisciplinary surgical planning, contributing to better consent process and enhancing patient safety. Methods We used 2D abdominal MRI to create a 3D model of kidneys, abdominal aorta, IVC and pancreas. Segmentation, the process of converting 2D slice data CTA scans to 3D surface models, was completed in Materialise Mimics. This surface model was exported as an STL file and then printed using a Stratasys Objet260 Connex3 polyjet printer. Soluble support was used for minimal post-print clean up. All of this in the laboratory at Great Ormond Street Hospital for Children. Results The first patient was a 7 year old girl with a background of neurofibromatosis type 1 who underwent left nephrectomy and had 7 angioplasties on the remaining right kidney. An aortic bypass was performed and the kidney was successfully auto-transplanted onto the right iliac vessels. The second patient was a 2 year old boy with middle aortic syndrome in which a bypass was performed from the thoracic aorta to the aortic iliac bifurcation with successful bilateral renal auto-transplantation. 3D models allowed the team for better planning of surgical approach and in the first case, initially planned surgical approach was amended once the model was reviewed. Patients and families commented that seeing the model made them better understand the operation and it contributed to better patient information and consenting pathway. Conclusions This is the first report on the use of the 3D printing for planning of complex vascular surgeries involving major arteries in children with renovascular hypertension and associated severe middle aortic syndrome. Both cases were successfully performed and 3D models benefitted both the surgical and medical planning, enhances safety of complex procedures,; as well as improving family understanding of the complexity of the procedure and adding to the quality of informed consent.